Dr. Paul Epp, MD

NPI: 1770592461
Total Payments
$1,783
2024 Payments
$28.34
Companies
18
Transactions
115
Medicare Patients
935
Medicare Billing
$148,578

Payment Breakdown by Category

Food & Beverage$1,783 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,783 115 100.0%

Top Paying Companies

Company Total Records Latest Year
Otsuka America Pharmaceutical, Inc. $396.79 25 $0 (2021)
Sunovion Pharmaceuticals Inc. $286.73 23 $0 (2021)
Janssen Pharmaceuticals, Inc $263.51 17 $0 (2022)
Alkermes, Inc. $201.50 10 $0 (2019)
Allergan, Inc. $153.36 9 $0 (2020)
Teva Pharmaceuticals USA, Inc. $79.20 6 $0 (2020)
Lundbeck LLC $68.90 4 $0 (2019)
Takeda Pharmaceuticals U.S.A., Inc. $58.45 3 $0 (2019)
Vanda Pharmaceuticals Inc. $54.23 3 $0 (2019)
AbbVie Inc. $37.55 2 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $28.34 2 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($28.34)
2022 $12.72 1 Janssen Pharmaceuticals, Inc ($12.72)
2021 $121.76 7 AbbVie Inc. ($37.55)
2020 $76.40 5 Otsuka America Pharmaceutical, Inc. ($30.00)
2019 $656.09 39 Alkermes, Inc. ($134.96)
2018 $548.91 36 Otsuka America Pharmaceutical, Inc. ($192.47)
2017 $338.48 25 Janssen Pharmaceuticals, Inc ($85.32)

All Payment Transactions

115 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
10/17/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $14.22 General
Category: PSYCHIATRY
06/13/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $14.12 General
Category: PSYCHIATRY
09/15/2022 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $12.72 General
Category: Neuroscience
09/02/2021 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $13.25 General
Category: PSYCHOLOGY
08/05/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $18.50 General
Category: NEUROSCIENCE
07/29/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $19.05 General
Category: NEUROSCIENCE
07/28/2021 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $12.56 General
Category: CNS
07/22/2021 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA, INVEGA Food and Beverage In-kind items and services $18.72 General
Category: Neuroscience
06/25/2021 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $17.88 General
Category: PSYCHIATRY
06/03/2021 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $21.80 General
Category: CNS
03/02/2020 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $15.00 General
Category: PSYCHIATRY
02/05/2020 Allergan, Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.34 General
Category: NEUROSCIENCE
01/10/2020 Teva Pharmaceuticals USA, Inc. AJOVY (Biological) Food and Beverage In-kind items and services $13.18 General
Category: Central Nervous System
01/08/2020 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $18.88 General
Category: CNS
01/07/2020 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $15.00 General
Category: PSYCHIATRY
12/11/2019 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $24.22 General
Category: CNS
12/02/2019 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $15.83 General
Category: CNS
10/30/2019 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), SPRAVATO Food and Beverage In-kind items and services $15.04 General
Category: Neuroscience
10/28/2019 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $21.38 General
Category: CNS
10/17/2019 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $15.81 General
Category: CNS
10/09/2019 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $20.34 General
Category: CNS
09/19/2019 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $15.91 General
Category: PSYCHIATRY
09/12/2019 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $12.08 General
Category: PSYCHIATRY
09/06/2019 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $14.98 General
Category: CNS
09/05/2019 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Food and Beverage In-kind items and services $11.44 General
Category: Central Nervous System (CNS)

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 183 477 $106,440 $32,697
2022 8 194 486 $81,872 $29,351
2021 8 261 574 $105,194 $38,071
2020 8 297 763 $128,252 $48,459
Total Patients
935
Total Services
2,300
Medicare Billing
$148,578
Procedure Codes
32

All Medicare Procedures & Services

32 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90870 Therapy using electrical currents Facility 2023 17 152 $48,944 $11,882 24.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 24 95 $15,204 $5,637 37.1%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 32 52 $14,309 $4,534 31.7%
90792 Psychiatric diagnostic evaluation with medical services Facility 2023 28 30 $8,670 $3,977 45.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 29 49 $5,738 $2,000 34.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 22 34 $5,654 $1,714 30.3%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 12 42 $4,250 $1,593 37.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 19 23 $3,671 $1,361 37.1%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 31 118 $15,576 $6,393 41.0%
90870 Therapy using electrical currents Facility 2022 17 75 $24,150 $5,348 22.1%
90792 Psychiatric diagnostic evaluation with medical services Facility 2022 33 37 $10,693 $4,958 46.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 31 111 $12,257 $4,823 39.3%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 30 38 $7,220 $3,025 41.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 18 31 $5,037 $1,889 37.5%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 14 36 $3,960 $1,787 45.1%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 20 40 $2,979 $1,129 37.9%
90870 Shock treatment and monitoring Facility 2021 19 116 $37,352 $9,513 25.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 49 122 $16,104 $6,655 41.3%
90792 Psychiatric diagnostic evaluation with medical services Facility 2021 45 49 $14,161 $6,368 45.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 36 113 $12,477 $5,398 43.3%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 49 54 $10,260 $4,249 41.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 21 37 $5,839 $2,231 38.2%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 27 67 $4,891 $1,983 40.5%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 15 16 $4,110 $1,673 40.7%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 61 212 $27,984 $11,996 42.9%

About Dr. Paul Epp, MD

Dr. Paul Epp, MD is a Psychiatry healthcare provider based in Saint Joseph, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770592461.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Epp, MD has received a total of $1,783 in payments from pharmaceutical and medical device companies, with $28.34 received in 2024. These payments were reported across 115 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,783).

As a Medicare-enrolled provider, Epp has provided services to 935 Medicare beneficiaries, totaling 2,300 services with total Medicare billing of $148,578. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Saint Joseph, MO
  • Active Since 08/05/2006
  • Last Updated 11/20/2017
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1770592461

Products in Payments

  • LATUDA (Drug) $286.73
  • ABILIFY MAINTENA (Drug) $270.93
  • INVEGA SUSTENNA (Drug) $263.51
  • REXULTI (Drug) $194.76
  • VRAYLAR (Drug) $190.91
  • ARISTADA (Drug) $134.96
  • Aristada 441 mg (Drug) $66.54
  • AUSTEDO (Drug) $66.02
  • Trintellix (Drug) $58.45
  • Fanapt (Drug) $54.23
  • INGREZZA (Drug) $32.33
  • NeuroStar TMS Therapy (Device) $31.36
  • CAPLYTA (Drug) $28.34
  • NUEDEXTA (Drug) $26.90
  • VYVANSE (Drug) $24.57
  • Adzenys XR-ODT (Drug) $14.71
  • QELBREE (Drug) $13.25
  • AJOVY (Biological) $13.18
  • NUPLAZID (Drug) $11.02

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Saint Joseph